Skip to main content
. 2009 Mar 12;3:38–42. doi: 10.2174/1874306400903010038

Fig. (5).

Fig. (5)

Increase from baseline in the Forced Vital Capacity (FVC) in subjects treated with the new beclomethasone/formoterol combination in extra-fine HFA formulation, in comparison with the traditional fluticasone/salmeterol combination. In both groups, FVC progressively increased, but this increase was significantly better with the new beclomethasone/formoterol combination [16].